@stemcellsciencenews.com@sydney.edu.au researchers identify dihydroorotate dehydrogenase inhibition as the dominant driver of QC6352 and zavondemstat antiglioblastoma efficacy.
Read the #OpenAccess paper published in @natchembio.nature.com here: https://go.nature.com/4AY42i8
